Product Description: Rocepafant (BN 50730) is a specific platelet activating factor (PAF) antagonist. Rocepafant can be used in rheumatoid arthritis and nervous system research[1].
Applications: COVID-19-immunoregulation
Formula: C26H23ClN6OS2
References: [1]Silva CL,et al. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes. Biochem Pharmacol. 1996 Jan 26;51(2):193-6.
CAS Number: 132579-32-9
Molecular Weight: 535.08
Research Area: Inflammation/Immunology; Cardiovascular Disease
Target: Platelet-activating Factor Receptor (PAFR)